Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension-Reference-Cited by-同舟云学术

Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension

Published:2009-09 Issue:3 Volume:51 Page:468-474
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Manolakopoulos Spilios,Triantos Christos,Theodoropoulos Jiannis,Vlachogiannakos Jiannis,Kougioumtzan Anastasios,Papatheodoridis George,Tzourmakliotis Dimitrios,Karamanolis Dimitrios,Burroughs Andrew K.,Archimandritis Athanasios,Raptis Sotirios,Avgerinos Alec

Publisher

Elsevier BV

Subject

Hepatology

Reference31 articles.

1. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients;Planas;J Hepatol,2004

2. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?;Armonis;Hepatology,1997

3. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis;Ripoll;Gastroenterology,2007

4. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study;Vorobioff;Gastroenterology,1996

5. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis;Villanueva;J Hepatol,2004

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Treatment of Portal Hypertension;Clinics in Liver Disease;2024-08

2. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine;Frontiers in Pharmacology;2024-07-16

3. Novel approaches in the medical management of compensated cirrhosis;Expert Review of Gastroenterology & Hepatology;2024-05-28

4. Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting;Liver Transplantation;2024-05-28

5. Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study;BMC Gastroenterology;2024-04-12